You are here


Screening, prognostic, predictive and diagnostic biomarkers. Non-invasive and tissue-based cancer biomarkers are available for licensing or collaborative development.

The integrin avß6 is an exciting emerging target for both imaging and therapy across many common tumour types including pancreatic, breast, oesophagus, head and neck, skin, lung and ovarian.

Read more

The Tyrer-Cuzick model is a breast cancer risk assessment tool incorporating family history, endogenous hormonal factors, benign disease, risk factors such as age and body mass index, as well as ge

Read more